Scribe Therapeutics


Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

Employees

51-200

Links


Org chart

Hiring!

Benjamin L. Oakes
Co-Founder, President & CEO
Collapse
Brett T. Staahl
Co-Founder & VP, External Innovation
Svetlana Lucas
Chief Business Officer
Vera Switek
VP, Talent
Sunny Mok
VP, Program Management
Shilpa Shroff
VP, Process Sciences
Michelle Eggers
Senior Director, Preclinical Study Management
Ed Sterling II
Director, Information Technology At Scribe Therapeutics
Oleh Krupa
Senior Scientist II
Wardah Masud
Research Associate, Therapeutic Discovery
Autoosa Salari
Sr. Scientist
Kai-Yuan Chen
Director of Data Science and Tech Platform

Board & advisors

Vijay Pande
Director
David F. Savage
Co-Founder & Scientific Advisor
Jennifer A. Doudna
Co-Founder & Scientific Advisor